Gout
252
20
31
166
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
63 trials with published results (25%)
Research Maturity
166 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.0%
10 terminated out of 252 trials
94.3%
+7.7% vs benchmark
21%
54 trials in Phase 3/4
38%
63 of 166 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 166 completed trials
Clinical Trials (252)
Metformin in Safety and Efficacy in Gouty Patients
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Evaluation of the Impact of Dietary Education and Intervention on Gout Patients Receiving Urate-Lowering Therapy
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
Mazdutide for Weight Management and Gout in Adults With Obesity
Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic Patients
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
Tight Control of Gouty Arthritis Compared to Usual Care
Long-Term Risk of Gout in Living Kidney Donors
Tigulixostat (IBI128) vs Febuxostat in Gout
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
The Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot Gout
Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With Gout
An Innovative Chinese Herbal Formula for the Treatment of Gout
Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout